@article{18149568de0c4e1ea8f07060a551f1ae,
title = "Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders",
keywords = "Immune checkpoint inhibitor-related eosinophilic gastrointestinal disorders, Immune-related adverse event, Non-small cell lung cancer, Pembrolizumab, Secondary hypereosinophilic syndrome",
author = "Masakatsu Nakamura and Toshimi Otsuka and Motona Kumagai and Tomiyasu Arisawa",
year = "2022",
doi = "10.2169/internalmedicine.7725-21",
language = "English",
volume = "61",
pages = "267--269",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "2",
}